Phase 2 Malignant Melanoma trials recruiting now
All Malignant Melanoma trials, every phase
9
Phase 2 recruiting
Other phases for Malignant Melanoma
Phase 2 Malignant Melanoma trials
- A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
- A Randomized Controlled Phase II Trial With Intradermal IMO-2125 in Pathological Tumor Stage (p) T3-4 cN0M0 Melanoma
- AMT-253 in Patients With Advanced Solid Tumours
- An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors
- GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
- Melanoma Metastasized to the Brain and Steroids
- Modified Vaccine for High Risk or Low Residual Melanoma Patients
- Preoperative Planning With PSMA-PET in Melanoma Surgery Trial
- RAPA-201 Therapy of Solid Tumors
Common questions
What does Phase 2 mean?
Is this list complete?
No. For the full record, search ClinicalTrials.gov.